Cannabis instead of opiates

Study of 3,000 patients shows: cannabis therapy is a substitute for other medication for 21% of patients

One in five cannabis patients is undergoing treatment to replace their previous conventional medication. This is shown by a study by Grünhorn, in the first part of which 3,090 cannabis patients were surveyed.

For example, 21 percent stated that they use cannabis to stop taking other medications. A further seven percent use cannabis to alleviate symptoms of conditions such as cluster headaches, glaucoma and restless leg syndrome or even tinnitus and PTSD. In addition, ADHD patients report that the very severe side effects of their prescribed medication no longer occur as a result of alternative cannabis therapy.

"This makes it clear that cannabis is a real option for improving the lives of patients. Above all, it is a therapeutic option to opiates or other addictive medications. Even tinnitus could be treated better with cannabis in that, for example, the sleep-disturbing symptoms were alleviated"" explains Dr. Nadine Herwig, Head of the Grünhorn Academy.

The multi-part study was conducted by the Grünhorn Academy, the education and training platform of Grünhorn, the largest German provider of prescription cannabis. In the first part of the study, respondents were asked to state which symptoms or illnesses they had been prescribed cannabis for, when they started their cannabis therapy, which symptoms it treated, how many flower varieties or capsules or extracts they had tried in the meantime and in which form they preferred to take cannabis.


Corporate Communications
Grünhorn Service GmbH
Permoserstraße 19
04318 Leipzig

E-Mail: presse@gruenhorn.de

About the Grünhorn Network 

Grünhorn is the umbrella brand for the largest German cannabis network, founded in Leipzig in 2020. This includes, among others: the largest online pharmacy for cannabis, gruenhorn.de, Schurer Pharma & Cosmetics GmbH, which provides automated fulfillment and logistics services for cannabis-leading pharmacies, and the Canymed GmbH, a nationwide pharmaceutical wholesaler for medical cannabis. As a leading cannabis health brand, Grünhorn stands for high-quality and innovative products and research in the field of medical cannabis.